Basic Information
Renovion, founded in 2013, is on a mission to transform the treatment of chronic inflammatory lung diseases. The company is currently developing clinical programs related to its lead therapeutic candidate, ARINA-1. ARINA-1 is an inhaled therapy designed to improve mucus clearance and reduce inflammation in patients diagnosed with chronic lung conditions.
RENOVION, INC.
NorthCarolina,United States of America
less than 15 people
January 01, 2013
info@mnhtndose.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios